Valuation: Dr. Reddy's Laboratories Limited

Market Cap 983B 50.83B 10.15B 9.06B 8.45B 7.68B 14.45B 14.59B 102B 39.7B 499B 38.1B 37.28B 1,606B P/E 2027 *
26.7x
P/E 2028 * 20.5x
Enterprise Value 951B 49.18B 9.82B 8.77B 8.18B 7.43B 13.98B 14.12B 98.21B 38.41B 483B 36.87B 36.07B 1,554B EV / Sales 2027 *
2.7x
EV / Sales 2028 * 2.37x
Free-Float
69.69%
Yield 2027 *
0.64%
Yield 2028 * 0.71%
1 day-3.19%
1 week-6.96%
Current month-6.26%
1 month-6.26%
3 months-2.15%
6 months-9.48%
Current year-16.14%
1 week 10.03
Extreme 10.03
10.36
1 month 10.03
Extreme 10.03
10.78
Current year 10.03
Extreme 10.03
12.81
1 year 10.03
Extreme 10.03
12.81
3 years 10.03
Extreme 10.03
16.34
5 years 9.1
Extreme 9.102
16.34
10 years 9.1
Extreme 9.102
16.34
Manager TitleAgeSince
Chief Executive Officer 59 2019-06-30
Director of Finance/CFO - 2024-07-31
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 2014-05-12
Chairman 65 2013-04-01
Director/Board Member 65 2018-10-24
Change 5-day change 1-year change 3-year change Capi.($)
-3.19%-6.96% - - 10.35B
-3.39%-0.70%+35.02%+99.71% 1,060B
-1.34%-2.25%+33.29%+59.48% 623B
-1.45%+2.28%+14.96%+78.29% 480B
-1.53%-3.00%+61.46%+33.49% 352B
-2.03%+1.06%+21.08%+40.60% 345B
-1.92%-0.29%+10.54%+33.58% 274B
-2.36%-1.16%-7.14%+9.54% 249B
-2.29%-1.53%+36.12%+47.69% 223B
-0.80%-1.80%+22.49%+92.98% 182B
Average -2.04%-0.48%+25.31%+55.04% 420.89B
Weighted average by Cap. -2.17%+0.04%+28.30%+64.73%

Financials

2027 *2028 *
Net sales 352B 18.2B 3.63B 3.24B 3.03B 2.75B 5.17B 5.22B 36.34B 14.21B 179B 13.64B 13.35B 575B 393B 20.33B 4.06B 3.62B 3.38B 3.07B 5.78B 5.84B 40.6B 15.88B 200B 15.24B 14.91B 642B
Net income 36.59B 1.89B 378M 337M 315M 286M 538M 543M 3.78B 1.48B 18.59B 1.42B 1.39B 59.79B 48.56B 2.51B 501M 448M 418M 379M 714M 721M 5.01B 1.96B 24.68B 1.88B 1.84B 79.36B
Net Debt -31.94B -1.65B -330M -294M -275M -250M -470M -474M -3.3B -1.29B -16.23B -1.24B -1.21B -52.19B -51.42B -2.66B -531M -474M -442M -402M -756M -763M -5.31B -2.08B -26.13B -1.99B -1.95B -84.04B
Projected Income Statement - Annual - Dr. Reddy's Laboratories Limited
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
26-10-08 R$10.03 -3.19% 1,500
26-10-06 R$10.36 -3.90% 13
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Dr. Reddy's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,202.40INR
Average target price
1,277.97INR
Spread / Average Target
+6.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Dr. Reddy's Laboratories Limited